Invention Application
US20140220100A1 VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION 审中-公开
用于超导管理的疫苗组合物

VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION
Abstract:
The invention provides a cancer vaccine composition for transdermal administration for inducing cellular immunity comprising (i) HER2/neu E75 peptide and/or a modified HER2/neu E75 peptide; and (ii) a first cellular immunity induction promoter.
Information query
Patent Agency Ranking
0/0